AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 9924711
Drug: Co-amoxiclav 625
RxNorm normalized name: CO
DrugBank: Carbon monoxide (DB11588)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Co-amoxiclav 625 mg orally three times daily for 5-10 days (n = 153)
Trial: 9419764
Drug: Estrogen alone
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estrogen alone (0.625 mg conjugated equine estrogen for 6 months)
Trial: 9419764
Drug: Estrogen with
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estrogen with progestin (0.625 mg conjugated equine estrogen with 10 mg medroxyprogesterone acetate for 10 days each month for 6 months)
Trial: 9419764
Drug: Insulin tolerance
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin tolerance test (ITT) and frequently sampled intravenous glucose tolerance test (FSIVGTT)
Trial: 29661378
Drug: Sodium nitroprusside
RxNorm normalized name: Sodium Nitroprusside
DrugBank: Nitroprusside (DB00325)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Sodium nitroprusside 0.5 μg kg-1 min-1 during RS-ketamine infusion
Trial: 29661378
Drug: Placebo during
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo during RS-ketamine infusion
Trial: 29661378
Drug: Sodium nitroprusside
RxNorm normalized name: Sodium Nitroprusside
DrugBank: Nitroprusside (DB00325)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Sodium nitroprusside 0.5 μg kg-1 min-1 during esketamine infusion
Trial: 29661378
Drug: Placebo during
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo during esketamine infusion
Trial: 14653298
Drug: Baseline and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baseline and disk treatment
Trial: 10523001
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human GH treatment (0.15 IU/kg x day) for 1 week
Trial: 8619701
Drug: Coenzyme Q10
RxNorm normalized name: Coenzyme Q10
DrugBank: Ubidecarenone (DB09270)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Coenzyme Q10 (600 mg in divided doses 12 hours before operation)
Trial: 16829774
Drug: Smoking cessation
RxNorm normalized name: Zyban 150 MG Smoking Cessation 12 HR Extended Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Smoking cessation interventions for smokers addicted to illicit drugs, alcohol, or both
Trial: 11308434
Drug: St John's
RxNorm normalized name: St john's wort
DrugBank: St. John's Wort (DB01323)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: St John's wort extract (900 mg/d for 4 weeks, increased to 1200 mg/d if no adequate response)
Trial: 9257200
Drug: Ketorolac 60
RxNorm normalized name: ketorolac 60 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketorolac 60 mg i.v. for dose 1, placebo for dose 2, ketorolac 30 mg i.v. for doses 3, 4, and 5 (Group 2)
Trial: 9257200
Drug: Ketorolac 60
RxNorm normalized name: ketorolac 60 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketorolac 60 mg i.v. for dose 1, ketorolac 30 mg i.v. for doses 3, 4, and 5 (Group 1)
Trial: 9257200
Drug: Placebo for
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo for all doses (Group 3)
Trial: 8305166
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg nitrendipine once daily for 12 weeks
Trial: 8305166
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg cilazapril once daily for 12 weeks
Trial: 22459388
Drug: Vitamin D
RxNorm normalized name: Vitamin D
DrugBank: Vitamin D (DB11094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D supplementation (100,000 units of oral vitamin D3)
Trial: 8997575
Drug: Maxitrol (neomycin
RxNorm normalized name: Maxitrol (neomycin 3.5 MG / polymyxin b 10,000 UNT / dexAMETHasone 1 MG) per GM Ophthalmic Ointment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maxitrol (neomycin sulphate 3500 IU/mL, polymyxin‐B sulphate 6000 IU/mL with dexamethasone 0.1%)
Trial: 1617932
Drug: cefaclor 250
RxNorm normalized name: cefaclor 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: cefaclor 250 mg three times daily
Trial: 26486011
Drug: Dydrogesterone 20
RxNorm normalized name: Dydrogesterone
DrugBank: Dydrogesterone (DB00378)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dydrogesterone 20 mg twice daily (n=96)
Trial: 26486011
Drug: Micronized progesterone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Micronized progesterone 400 mg twice daily (n=114)
Trial: 15259296
Drug: Controlled-release oxycodone
RxNorm normalized name: oxycodone
DrugBank: Oxycodone (DB00497)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Controlled-release oxycodone (CRO) 10 mg, administered twice in the first 24 hours postoperatively
Trial: 15259296
Drug: Intravenous tramadol/metamizol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous tramadol/metamizol (TM) 100 mg tramadol + 1 g metamizol every 4 h for 24 h, placebo tablet at recovery
Trial: 12099518
Drug: Cyclosporine microemulsion
RxNorm normalized name: cyclosporine microemulsion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclosporine microemulsion absorption profiling (AUC)
Trial: 12099518
Drug: Conventional trough-level
RxNorm normalized name: rough marshelder pollen extract
DrugBank: Iva annua pollen (DB10927)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional trough-level drug monitoring (C0)
Trial: 12099518
Drug: C2 values
FDA approved: no
EMA approved: no
PMDA approved: no
Description: C2 values above approximately 1500 microg/L by day 3 post-transplant
Trial: 10233191
Drug: PAM (pantoprazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PAM (pantoprazole 40 mg o.d. plus amoxycillin 1 g b.d. and metronidazole 250 mg q.d.s.)
Trial: 10233191
Drug: PCM (pantoprazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PCM (pantoprazole 40 mg o.d. plus clarithromycin 250 mg b.d. and metronidazole 250 mg q.d.s.)
Trial: 10233191
Drug: PAC (pantoprazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PAC (pantoprazole 40 mg o.d. plus amoxycillin 1 g b.d. and clarithromycin 250 mg b.d.)
Trial: 2112516
Drug: Nitroglycerin (0.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitroglycerin (0.8 mg)
Trial: 623044
Drug: Amino acids
RxNorm normalized name: Amino acids
DrugBank: Amino acids (DB09393)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amino acids alone (1 g/kg per day)
Trial: 623044
Drug: Amino acids
RxNorm normalized name: Amino acids
DrugBank: Amino acids (DB09393)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amino acids plus 100 g glucose daily
Trial: 26428452
Drug: Tdap vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tdap vaccine information statement (VIS)
Trial: 20709992
Drug: Conjugated equine
RxNorm normalized name: Conjugated equine estrogens
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conjugated equine estrogen (0.625 mg tablet once daily)
Trial: 19040336
Drug: Orlistat 120
RxNorm normalized name: orlistat 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orlistat 120 mg, three times daily for 6 months (O group)
Trial: 19040336
Drug: Ezetimibe 10
RxNorm normalized name: ezetimibe 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ezetimibe 10 mg/day for 6 months (E group)
Trial: 19040336
Drug: Orlistat 120
RxNorm normalized name: orlistat 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orlistat 120 mg and Ezetimibe 10 mg/day for 6 months (OE group)
Trial: 15867169
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of atorvastatin and irbesartan
Trial: 9493502
Drug: Caffeine at
RxNorm normalized name: Caffeine
DrugBank: Caffeine (DB00201)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Caffeine at 3 mg/kg bodyweight
Trial: 9493502
Drug: Caffeine at
RxNorm normalized name: Caffeine
DrugBank: Caffeine (DB00201)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Caffeine at 1 mg/kg bodyweight
Trial: 28619
Drug: Benorylate (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Benorylate (6 g/day)
Trial: 28618737
Drug: Artcure Diffusional
RxNorm normalized name: LUNG DIFFUSION GAS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Artcure Diffusional Patch
Trial: 28618737
Drug: Placebo transdermal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo transdermal diffusional patch
Trial: 19589242
Drug: Simvastatin (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin (6 months treatment)
Trial: 19589242
Drug: Routine therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine therapy alone (control group)
Trial: 11784832
Drug: Detailed cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Detailed cognitive assessment and treatment programme
Trial: 9701525
Drug: Eradication regimens
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eradication regimens based on omeprazole plus antibiotics and bismuth plus antibiotics
Trial: 25075
Drug: Acebutolol (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acebutolol (300 mg)
Trial: 1234486
Drug: Practolol (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Practolol (400 mg)
Trial: 30859680
Drug: Standard omeprazole
RxNorm normalized name: Omeprazole
DrugBank: Omeprazole (DB00338)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Standard omeprazole doses
Trial: 30859680
Drug: Personalized therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Personalized therapy based on CYP2C19 polymorphism
Trial: 28371078
Drug: 10% D/DC-containing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10% D/DC-containing cream
Trial: 28371078
Drug: 20% D/DC-containing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20% D/DC-containing cream
Trial: 26460279
Drug: Prasugrel (loading/maintenance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prasugrel (loading/maintenance dose: 20/3.75 mg)
Trial: 26460279
Drug: Clopidogrel (loading/maintenance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel (loading/maintenance dose: 300/75 mg)
Trial: 23181738
Drug: Ingesting all
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ingesting all prescribed once-a-day hypertension medications upon awakening
Trial: 23181738
Drug: Bedtime hypertension
RxNorm normalized name: Buckley's Bedtime Formula
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bedtime hypertension treatment
Trial: 17917685
Drug: Immediate Sequential
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate Sequential Cataract Surgery (ISCS)
Trial: 17917685
Drug: Delayed Sequential
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delayed Sequential Cataract Surgery (DSCS)
Trial: 11571822
Drug: Active treatment
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active treatment (impulse magnetic-field therapy, 16 Hz, 5 microTs)
Trial: 9784038
Drug: Oral Imedeen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral Imedeen
Trial: 28719008
Drug: Gemigliptin (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemigliptin (50 mg)
Trial: 22943969
Drug: Heated patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heated patch (4 lidocaine/tetracaine patches, 70/70 mg) for 2 hours
Trial: 22943969
Drug: Heated patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heated patch (4 lidocaine/tetracaine patches, 70/70 mg) for 4 hours
Trial: 22943969
Drug: Heated patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heated patch (4 lidocaine/tetracaine patches, 70/70 mg) for 12 hours
Trial: 22943969
Drug: Unheated patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unheated patch (4 lidocaine/tetracaine patches, 70/70 mg) for 4 hours
Trial: 22943969
Drug: Heated patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heated patch (4 lidocaine/tetracaine patches, 70/70 mg)
Trial: 21095263
Drug: Ezetimibe 10
RxNorm normalized name: ezetimibe 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ezetimibe 10 mg plus Simvastatin 20 mg daily
Trial: 18692886
Drug: Levalbuterol HFA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levalbuterol HFA MDI (45 microg per dose)
Trial: 18692886
Drug: Racemic albuterol
RxNorm normalized name: Albuterol
DrugBank: Albuterol (DB01001)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Racemic albuterol HFA MDI (90 microg per dose)
Trial: 15960560
Drug: Duloxetine (80-120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Duloxetine (80-120 mg/day)
Trial: 12610044
Drug: Pioglitazone (45
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pioglitazone (45 mg o.d. for >26 weeks)
Trial: 7669958
Drug: Low loading
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low loading dose of milrinone (20 micrograms/kg during 15 minutes)
Trial: 7669958
Drug: High loading
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High loading dose of milrinone (40 micrograms/kg during 15 minutes)
Trial: 6770673
Drug: Cefaclor (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefaclor (40 mg/kg/day for 10 days to 3 weeks)
Trial: 6770673
Drug: Amoxicillin trihydrate
RxNorm normalized name: Amoxicillin Trihydrate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin trihydrate (40 mg/kg/day for 10 days to 3 weeks)
Trial: 6770673
Drug: Penicillin V
RxNorm normalized name: Penicillin V
DrugBank: Phenoxymethylpenicillin (DB00417)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Penicillin V potassium (20 mg/kg/day for 10 days)
Trial: 28240983
Drug: Digits-in-noise (DIN)
RxNorm normalized name: hydralazine
DrugBank: Hydralazine (DB01275)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Digits-in-noise (DIN) test administered via personal computer
Trial: 23094264
Drug: Manual toothbrush
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Manual toothbrush (Oral‐B Advantage)
Trial: 23094264
Drug: Manual toothbrush
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Manual toothbrush (Oral‐B CrossAction)
Trial: 23094264
Drug: Manual toothbrush
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Manual toothbrush (Oral‐B ShinyClean)
Trial: 19823185
Drug: 1500 mg
RxNorm normalized name: inulin 1500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1500 mg dairy and non-dairy calcium
Trial: 19823185
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg dairy and non-dairy calcium
Trial: 18171957
Drug: Shock wave
RxNorm normalized name: ELECTRODE GEL,H-WAVE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Shock wave therapy (Group 2)
Trial: 16120776
Drug: Placebo with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo with expected analgesic properties
Trial: 12590855
Drug: Moxifloxacin (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moxifloxacin (400 mg, 7-day regimen)
Trial: 12590855
Drug: Trovafloxacin (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trovafloxacin (200 mg, 10-day regimen)
Trial: 8452170
Drug: Amoxicillin 500
RxNorm normalized name: amoxicillin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin 500 mg every 8 hours for 7 days
Trial: 3540918
Drug: Tripotassium dicitrato
RxNorm normalized name: Tripotassium dicitratobismuthate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tripotassium dicitrato bismuthate (TDB) administered twice daily
Trial: 3540918
Drug: Tripotassium dicitrato
RxNorm normalized name: Tripotassium dicitratobismuthate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tripotassium dicitrato bismuthate (TDB) administered four times daily
Trial: 22024905
Drug: High-dose supervised
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose supervised strengthening exercise with spinal manipulation (ET + SMT)
Trial: 22024905
Drug: High-dose supervised
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose supervised strengthening exercise (ET)
Trial: 19606689
Drug: Johrei treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Johrei treatment (18 sessions over 6 weeks)
Trial: 20424424
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment (n = 43)
Trial: 15720887
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of nevirapine (NVP)
Trial: 15720887
Drug: NVP with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NVP with zidovudine (ZDV) twice daily for a week
Trial: 6214377
Drug: Topical erythromycin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical erythromycin 1.5 percent solution (Staticin solution)
Trial: 6214377
Drug: Oral tetracycline
RxNorm normalized name: Tetracycline
DrugBank: Tetracycline (DB00759)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral tetracycline (250 mg twice a day)
Trial: 30235940
Drug: Antiretroviral therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiretroviral therapy (ART) adherence
Trial: 31488063
Drug: Concurrent ART
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Concurrent ART and tuberculosis treatment
Trial: 31488063
Drug: Switching to
RxNorm normalized name: Wong To Yick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Switching to a second line ART regimen with higher pill burden
Trial: 28369381
Drug: Kaletra® 400/100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Kaletra® 400/100 mg plus tenofovir disoproxil/emtricitabine (200/245 mg) once daily
Trial: 1724233
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (disopyramide and mexiletine)
Trial: 1724233
Drug: Disopyramide and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Disopyramide and mexiletine combination
Trial: 31002475
Drug: Ilaprazole 10
RxNorm normalized name: ilaprazole
DrugBank: Ilaprazole (DB11964)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ilaprazole 10 mg once a day (QD) for 3 months (Group A)
Trial: 31002475
Drug: Ilaprazole 10
RxNorm normalized name: ilaprazole
DrugBank: Ilaprazole (DB11964)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ilaprazole 10 mg twice a day (BID) for 3 months (Group B)
Trial: 31002475
Drug: Ilaprazole 10
RxNorm normalized name: ilaprazole
DrugBank: Ilaprazole (DB11964)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ilaprazole 10 mg BID plus mosapride citrate 5 mg three times a day (TID) for 3 months (Group C)
Trial: 29345213
Drug: Matcha green
RxNorm normalized name: acid green 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Matcha green tea drinks (1 g of Matcha premium grade; OMGTea Ltd., Brighton, UK) consumed the day before and 2 hours before the walk
Trial: 21791662
Drug: Danoprevir (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Danoprevir (400 mg, 600 mg, and 900 mg twice daily) in combination with pegylated interferon α‐2a (180 μg once weekly) and ribavirin (1000‐1200 mg/day)
Trial: 21791662
Drug: Danoprevir (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Danoprevir (100 mg, 200 mg, and 300 mg 3 times daily) in combination with pegylated interferon α‐2a and ribavirin
Trial: 21791662
Drug: Placebo in
RxNorm normalized name: placebo INTRAVEN VIAL (ML)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo in combination with standard of care
Trial: 9642510
Drug: MMF 3
RxNorm normalized name: MMF
DrugBank: Monomethyl fumarate (DB14219)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MMF 3 g/d with low cyclosporine and steroid doses
Trial: 8033372
Drug: Salbutamol (SAL,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salbutamol (SAL, 0.08 mg/kg orally)
Trial: 8033372
Drug: Arginine (ARG,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Arginine (ARG, 0.5 g/kg i.v.)
Trial: 8033372
Drug: Pyridostigmine (PD,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pyridostigmine (PD, 120 mg orally)
Trial: 30255228
Drug: Potassium bicarbonate
RxNorm normalized name: Potassium Bicarbonate
DrugBank: Potassium bicarbonate (DB11098)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Potassium bicarbonate (KHCO3) supplementation (90 mmol daily) during bed rest
Trial: 28751663
Drug: Paliperidone palmitate
RxNorm normalized name: Paliperidone Palmitate
DrugBank: Paliperidone (DB01267)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paliperidone palmitate long-acting injectables (1-monthly and 3-monthly)
Trial: 28751663
Drug: Switching from
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Switching from oral antipsychotics to long-acting injectables
Trial: 23819342
Drug: Atenolol (68.7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol (68.7 ± 4.17 mg/day)
Trial: 23819342
Drug: Amlodipine (5.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amlodipine (5.5 ± 0.34 mg/day)
Trial: 12612232
Drug: Minimal feeding
RxNorm normalized name: Centipeda minima whole extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Minimal feeding volumes (20 mL/kg/d for the first 10 days)
Trial: 12612232
Drug: Advancing feeding
RxNorm normalized name: SET,FEEDING
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Advancing feeding volumes (20 mL/kg/d on day 1, increased by 20 mL/kg/d up to 140 mL/kg/d)
Trial: 10839897
Drug: Intravenous clonidine
RxNorm normalized name: Clonidine
DrugBank: Clonidine (DB00575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous clonidine (1.5 microg/kg)